Chase Investment Counsel Corp Bristol Myers Squibb CO Transaction History

Chase Investment Counsel Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $188,241 - $219,445	-3,510 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$59.17 - $69.31 $207,686 - $243,278	3,510 New	3,510 $207,000
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $4.81 Million - $5.62 Million	-87,741 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $1.58 Million - $2.3 Million	34,036 Added 63.38%	87,741 $4.89 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $2.64 Million - $3.45 Million	53,705 New	53,705 $3.45 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.